PathMaker Neurosystems Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
PathMaker Neurosystems Inc. - overview
Established
2013
Location
Boston, MA, US
Primary Industry
Medical Devices & Equipment
About
PathMaker Neurosystems Inc. is an innovative company focused on developing non-invasive neuromodulation devices to treat severe neurological disorders, particularly amyotrophic lateral sclerosis (ALS). Founded in 2013 and headquartered in Boston, US, PathMaker Neurosystems specializes in neuromodulation technologies. The company is led by Nader Yaghoubi, who is also the founder.
It has not undergone any significant pivots or changes in business strategy since its inception. PathMaker remains a standalone entity without any known subsidiaries or parent companies. PathMaker Neurosystems specializes in the development of non-invasive neuromodulation devices aimed at treating neurological disorders, with a particular focus on amyotrophic lateral sclerosis (ALS). The company’s primary offering is its proprietary multi-site direct current stimulation (Multi-Site DCS) technology, designed to suppress neuronal hyperexcitability and activate neuronal protein degradation pathways.
By normalizing overactive neural pathways and reducing protein aggregation in motor neurons, the technology aims to restore functionality in patients with ALS and other serious neurological conditions. PathMaker’s solutions target clinical healthcare providers and institutions specializing in neurology, focusing on markets in North America and Europe, where there is a significant demand for innovative treatment options for ALS and related disorders. PathMaker Neurosystems generates revenue through the commercialization of its neuromodulation products, primarily engaging in direct transactions with healthcare providers and institutions. The company employs a structure where purchases are made directly by hospitals or clinics, establishing partnerships for distribution within the clinical environment.
Revenue streams include sales of devices as well as potential recurring revenue from ongoing support services or training. Specific details regarding pricing plans or transaction volumes are not publicly disclosed but are structured to reflect the clinical value delivered through the company's flagship technologies.
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare, Medical Devices & Equipment
Website
www.pmneuro.com
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.